Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs

References

• Agudelo D, Bérubé G, Tajmir-Riahi HA. (2016). An overview on the delivery of antitumor drug doxorubicin by carrier proteins. Int J Biol Macromol 88:1–13.
   PubMed Web of Science ®Google Scholar
• Akkari ACS, Papini JZB, Garcia GK, et al. (2016). Poloxamer 407/188 binary thermosensitive hydrogels as delivery systems for infiltrative local anesthesia: physico-chemical characterization and pharmacological evaluation. Mater Sci Eng C Mater Biol Appl 68:299–307.
   PubMed Web of Science ®Google Scholar
• Bhagat A, Kleinerman ES. (2020). Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention. Adv Exp Med Biol 1257:181–92.
   PubMed Web of Science ®Google Scholar
• Blum RH, Carter SK. (1974). Adriamycin. a new anticancer drug with significant clinical activity. Ann Intern Med 80:249–59.
   PubMed Web of Science ®Google Scholar
• Bujňáková Z, Baláž M, Zdurienčíková M, et al. (2017). Preparation, ­properties and anticancer effects of mixed As(4)S(4)/ZnS nanoparticles capped by Poloxamer 407. Mater Sci Eng C Mater Biol Appl 71:541–51.
   PubMed Web of Science ®Google Scholar
• Chen Y, Mo L, Wang X, et al. (2020). TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma in vitro and in vivo. Aging (Albany NY) 12:1624–42.
   PubMedGoogle Scholar
• Cheng W, Liang C, Xu L, et al. (2017). TPGS-functionalized polydopamine-modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance. Small 13:1700623.
   Web of Science ®Google Scholar
• Dintaman JM, Silverman JA. (1999). Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 16:1550–6.
   PubMed Web of Science ®Google Scholar
• Fantappiè O, Solazzo M, Lasagna N, et al. (2007). P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res 67:4915–23.
   PubMed Web of Science ®Google Scholar
• Fu Q, Lv P, Chen Z, et al. (2015). Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale 7:4020–30.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41.
   PubMed Web of Science ®Google Scholar
• Guan Y, Wang LY, Wang B, et al. (2020). Recent advances of D-α-tocopherol polyethylene glycol 1000 succinate based stimuli-responsive nanomedicine for cancer treatment. Curr Med Sci 40:218–31.
   PubMed Web of Science ®Google Scholar
• Hajnóczky G, Csordás G, Das S, et al. (2006). Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 40:553–60.
   PubMed Web of Science ®Google Scholar
• Hao T, Chen D, Liu K, et al. (2015). Micelles of d-α-tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance. ACS Appl Mater Interfaces 7:18064–75.
   PubMed Web of Science ®Google Scholar
• Jia L, Li Z, Shen J, et al. (2015). Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Int J Pharm 489:318–30.
   PubMed Web of Science ®Google Scholar
• Jin X, Li M, Yin L, et al. (2017). Tyroservatide-TPGS-paclitaxel liposomes: tyroservatide as a targeting ligand for improving breast cancer treatment. Nanomed 13:1105–15.
   PubMed Web of Science ®Google Scholar
• Kanwal U, Irfan Bukhari N, Ovais M, et al. (2018). Advances in nano-delivery systems for doxorubicin: an updated insight. J Drug Target 26:296–310.
   PubMed Web of Science ®Google Scholar
• Kumbhar PS, Nadaf S, Manjappa AS, et al. (2022). D-ɑ-tocopheryl polyethylene glycol succinate: a review of multifarious applications in nanomedicines. OpenNano 6:100036.
   Google Scholar
• Luo Y, Ziebell MR, Prestwich GD. (2000). A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 1:208–18.
   PubMed Web of Science ®Google Scholar
• Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. (2014). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in survivin-overexpressing breast cancer cells. Biochem Pharmacol 89:31–42.
   PubMed Web of Science ®Google Scholar
• Pawar VK, Singh Y, Meher JG, et al. (2014). Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release 183:51–66.
   PubMed Web of Science ®Google Scholar
• Rahman CV, Kuhn G, White LJ, et al. (2013). PLGA/PEG-hydrogel composite scaffolds with controllable mechanical properties. J Biomed Mater Res B Appl Biomater 101:648–55.
   PubMed Web of Science ®Google Scholar
• Rathod S, Bahadur P, Tiwari S. (2021). Nanocarriers based on vitamin E-TPGS: Design principle and molecular insights into improving the efficacy of anticancer drugs. Int J Pharm 592:120045.
   PubMedGoogle Scholar
• Ren X, Wang N, Zhou Y, et al. (2021). An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway. Acta Biomater 124:179–90.
   PubMed Web of Science ®Google Scholar
• Ruttala HB, Ko YT. (2015). Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf B Biointerfaces 128:419–26.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. (2022). Cancer statistics, 2022. CA A Cancer J Clinicians 72:7–33.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhu ZF, Cao LP, et al. (2020). [Thermosensitive gel of polysaccharide from Ganoderma applanatum combined with paclitaxel for mice with 4T1 breast cancer]. Zhongguo Zhong Yao Za Zhi 45:2533–9.
   PubMedGoogle Scholar
• Varma MV, Panchagnula R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25:445–53.
   PubMed Web of Science ®Google Scholar
• Vincze O, Colchero F, Lemaître JF, et al. (2022). Cancer risk across mammals. Nature 601:263–7.
   PubMed Web of Science ®Google Scholar
• Wang TH, Wang HS, Soong YK. (2000). Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88:2619–28.
   PubMed Web of Science ®Google Scholar
• Yang L, Xin J, Zhang Z, et al. (2016). TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo. J Pharm Pharmacol 68:1109–18.
   PubMed Web of Science ®Google Scholar
• Youk HJ, Lee E, Choi MK, et al. (2005). Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release 107:43–52.
   PubMed Web of Science ®Google Scholar
• Yu M, Zhang C, Tang Z, et al. (2019). Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity. Cancer Lett 442:396–408.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qi J, Zhang X, et al. (2022). The regulatory roles of mitochondrial calcium and the mitochondrial calcium uniporter in tumor cells. Int J Mol Sci 23:6667.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dosta P, Conde J, et al. (2020). Prolonged local in vivo delivery of stimuli-responsive nanogels that rapidly release doxorubicin in triple-negative breast cancer cells. Adv Healthc Mater 9:e1901101.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906.
   PubMed Web of Science ®Google Scholar